Nottingham Forest are trialling a new blood test that could predict footballers’ injuries

The study, backed by a company linked to the University of Glasgow, could open up new possibilities, including assessing players’ market value.
by Redazione Undici 9 November 2026 at 10:13

In football in 2026, injuries have become an obsession for managers, medical staff and clubs. Perhaps because they remain one of the few aspects of the game that cannot be reliably predicted, or because the fixture list has become so congested that squad rotation is no longer optional. Either way, clubs are devoting increasing resources to injury prevention and the monitoring of players’ physical condition, whether the problem is muscular or the result of a collision. Some are even turning to methods and tests that, on the face of it, might seem rather unusual.

One of the more intriguing examples is emerging at Nottingham Forest. The English club is trialling a new technology designed to identify biological signals that may precede an injury. The 12-week project, developed in partnership with Scottish biotech company Entourage, could offer a different approach to managing players’ health and extending their careers. The initial study will involve 25 players from Forest’s men’s second team, each providing two blood samples a week. These will be analysed to track thousands of proteins, building a detailed picture of how each player’s body responds to training, matches, injuries and the recovery process.

The findings will be compared with data already collected by the club on training loads, physical conditioning and players’ medical histories. The aim is to establish whether certain biological changes can provide an early indication of the risk of non-contact muscle injuries: those sustained without direct contact with an opponent. According to UEFA research, hamstring injuries alone accounted for one in five of all days missed through injury during the 2021/22 season. That was twice the proportion recorded twenty years earlier. A separate study of English professional football found that a hamstring injury results in an average absence of 19 days.

«One of the questions we’re trying to answer is whether there are signals in the blood that can indicate an increased risk of a non-contact injury», Patrick Gunning, professor and chief executive of Entourage, told The Independent. «That’s what we want to explore through this study. If athletes and their clubs could monitor factors that until now have been invisible to them, and use that information to look after their bodies, we might see more sportspeople competing at the highest level well into their forties and beyond».

The research is based on proteomics, the study of the proteins present in the body. Scientists will focus particularly on changes in biological markers associated with inflammation and the functioning of the immune system. They will also examine proteins linked to so-called senescent cells, often referred to as «zombie cells». These are cells that have stopped dividing but remain in the body, where they can contribute to persistent inflammation. The researchers want to understand how these markers change following an injury and throughout the recovery process. If the trial proves successful, the technology could become useful not only in preventing injuries but also in tailoring rehabilitation programmes to individual players. After all, footballers do not all respond in the same way to the physical demands placed on them.

«If we understand a player’s individual biology, we can begin to see what works for them and what doesn’t», Gunning added. «If a player’s inflammation levels remain significantly higher than those of a teammate after a match, that information could help the medical staff decide whether a different approach to recovery is needed». The trial will also help establish a biological profile specific to professional footballers, drawing on a database already compiled by Entourage that includes thousands of people aged between 18 and 96. The distinction matters: the biological profile of an elite athlete can differ considerably from that of the general population.

The ambitions behind the project extend well beyond injury prevention. Gunning has spoken of the possibility of creating a kind of «Moneyball of biological data»: scientific information that could sit alongside conventional statistics when assessing players, helping clubs gauge their likely availability over the course of a season and, in turn, their value in the transfer market. «The potential applications of this technology are enormous», he said. «In European football, for example, we could identify players with the potential to reach the very highest level. Smaller clubs, meanwhile, might find opportunities in signing players who are considered injury risks».

Entourage is a spin-off from the University of Glasgow, founded by Gunning alongside doctors Taleb Sedghi and Mark Lindsay. The company began operating with an initial investment of five million dollars, approximately £3.7 million, and conducts its research at Glasgow’s Kelvin Campus. According to Gunning, advances in analytical technology and data processing, particularly those made possible by artificial intelligence, have made the study of proteins faster and less expensive. The potential applications reach well beyond professional sport. Research has already explored the use of plasma proteomics in identifying cardiovascular disease, Alzheimer’s and type 2 diabetes.

«This could become a hugely significant medical study for sport, but its implications reach much further», Gunning said. At the end of the three-month trial, Entourage will present its findings to Nottingham Forest. For now, the question is whether a routine blood test might eventually offer clubs a way to spot the warning signs of injury, adapt recovery programmes and gain a clearer picture of how long a player can remain at the highest level.

>

Read also